These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 6845664

  • 21. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct 24; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract] [Full Text] [Related]

  • 22. [Experience in using inactivated influenza vaccine with persons at "high risk"].
    Rudenko LG, Zoshchenko NIa, Zykov MP, Fridman EA.
    Tr Inst Im Pastera; 1979 Oct 24; 52():55-9. PubMed ID: 550548
    [No Abstract] [Full Text] [Related]

  • 23. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 24; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 24. [Clinico-immunologic study of the use of 2 doses of inactivated influenza centrifuge vaccine].
    Lugovskaia VP, Subbotina TI, Sidorova LV, Ten'kova TV, Dadalova AI.
    Tr Inst Im Pastera; 1985 Sep 24; 63():74-8. PubMed ID: 3843160
    [No Abstract] [Full Text] [Related]

  • 25. [The focusing on and use of anti-influenza vaccines].
    Tyrrell DA, Schild GC, Dowdle WR, Chanock R, Murphy B.
    Bull World Health Organ; 1981 Sep 24; 59(4):519-28. PubMed ID: 6976223
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Influenza vaccine 2007-2008.
    Med Lett Drugs Ther; 2007 Oct 08; 49(1271):81-3. PubMed ID: 17912142
    [No Abstract] [Full Text] [Related]

  • 30. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB.
    J Infect Dis; 2001 Jan 15; 183(2):329-332. PubMed ID: 11110645
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cold-adapted, live attenuated intranasal influenza virus vaccine.
    Zangwill KM.
    Pediatr Infect Dis J; 2003 Mar 15; 22(3):273-4. PubMed ID: 12634591
    [No Abstract] [Full Text] [Related]

  • 36. [Methodological approach to evaluating the vaccinal prevention of influenza as an epidemic control measure].
    Rykushin IuP, Mukhina LP.
    Tr Inst Im Pastera; 1982 Mar 15; 59():55-9. PubMed ID: 6228045
    [No Abstract] [Full Text] [Related]

  • 37. [Evaluation of antibody formation in population of children vaccinated with inactivated influenza virus].
    Melluso G, Di Cerbo G, Boccacciaro M, D'Auria F, Richiello F.
    Nuovi Ann Ig Microbiol; 1982 Mar 15; 33(1):23-31. PubMed ID: 7187018
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.